154 related articles for article (PubMed ID: 38179)
1. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
Singleton JW; Summers RW; Kern F; Becktel JM; Best WR; Hansen RN; Winship DH
Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
[TBL] [Abstract][Full Text] [Related]
2. National Cooperative Crohn's Disease Study: results of drug treatment.
Summers RW; Switz DM; Sessions JT; Becktel JM; Best WR; Kern F; Singleton JW
Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
[TBL] [Abstract][Full Text] [Related]
3. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
[TBL] [Abstract][Full Text] [Related]
4. National Cooperative Crohn's Disease Study: adverse reactions to study drugs.
Singleton JW; Law DH; Kelley ML; Mekhjian HS; Sturdevant RA
Gastroenterology; 1979 Oct; 77(4 Pt 2):870-82. PubMed ID: 38177
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
[TBL] [Abstract][Full Text] [Related]
6. Azathioprine-related pancreatitis in patients with Crohn's disease.
Sturdevant RA; Singleton JW; Deren JL; Law DH; McCleery JL
Gastroenterology; 1979 Oct; 77(4 Pt 2):883-6. PubMed ID: 38178
[TBL] [Abstract][Full Text] [Related]
7. [Results of treatment with sulfasalazine in the American Multicenter Study on the treatment of Crohn disease (National Cooperative Crohn's Disease Study)].
Singleton JW
Z Gastroenterol Verh; 1981 Jun; 19():38-40. PubMed ID: 6168133
[No Abstract] [Full Text] [Related]
8. National Cooperative Crohn's Disease Study: study design and conduct of the study.
Winship DH; Summers RW; Singleton JW; Best WR; Becktel JM; Lenk LF; Kern F
Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
[TBL] [Abstract][Full Text] [Related]
10. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
11. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
Sachar DB; Rubin KP; Gumaste V
Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
[TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Steinhart AH; Hemphill D; Greenberg GR
Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
[TBL] [Abstract][Full Text] [Related]
13. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
Korelitz BI; Present DH
Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
[No Abstract] [Full Text] [Related]
14. Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial.
Lémann M; Mary JY; Duclos B; Veyrac M; Dupas JL; Delchier JC; Laharie D; Moreau J; Cadiot G; Picon L; Bourreille A; Sobahni I; Colombel JF;
Gastroenterology; 2006 Apr; 130(4):1054-61. PubMed ID: 16618399
[TBL] [Abstract][Full Text] [Related]
15. How should we treat Crohn's disease?
Sleisenger MH
N Engl J Med; 1980 May; 302(18):1024-6. PubMed ID: 6102738
[No Abstract] [Full Text] [Related]
16. Alternate-day prednisone treatment and treatment maintenance in Crohn's disease.
Bello C; Goldstein F; Thornton JJ
Am J Gastroenterol; 1991 Apr; 86(4):460-6. PubMed ID: 1672787
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III.
Malchow H; Steinhardt HJ; Lorenz-Meyer H; Strohm WD; Rasmussen S; Sommer H; Jarnum S; Brandes JW; Leonhardt H; Ewe K
Scand J Gastroenterol; 1990 Mar; 25(3):235-44. PubMed ID: 1969678
[TBL] [Abstract][Full Text] [Related]
18. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
[TBL] [Abstract][Full Text] [Related]
20. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.
Omer B; Krebs S; Omer H; Noor TO
Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
